We're crowdfunding! Own a part of our business. Capital at Risk.
View our pitch

Lorena Carmona Rodriquez as Senior Scientist to specifically progress mRNA-LNP programme.

Stablepharma Ltd is delighted to announce that Lorena Carmona-Rodiguez is joining the Science Team at our R&D Centre in Madrid, Spain. Lorena joins ‘The Fridge-free Vaccine Company’ as Senior Scientist to specifically progress our mRNA-LNP programme.

Lorena has a Master’s Degree and PhD in Molecular Biosciences from the Universidad Autónoma de Madrid. She was, until recently a Postdoctoral researcher at the National Biotechnology Centre (CNB-CSIC) at the department of macromolecular structure.

‘As we progress our portfolio of vaccines products and move towards the launch of the world’s first Tetanus diphtheria (SPXV02) fridge-free vaccine, we continue to expand our science team in Madrid. This is an exciting time for Stablepharma and we are delighted to welcome Lorena to support the team and advance our vaccine programmes, including mRNA-LNP”, said Özgür Tuncer, CEO & Executive Director of Stablepharma Ltd.

Currently, the ‘cold chain’ is a significant barrier to transporting and storing vaccines, particularly in countries with unreliable infrastructures. The WHO estimate that up to 50% of all vaccines manufactured currently lose their efficacy before they can be delivered, often as a result of ‘cold chain’/refrigeration failures.

“Our StablevaX™ technology addresses the challenges of the cold chain so that vaccines  can be transported and stored at room temperature, without the need for refrigeration or the risk of degradation’. ‘Stablepharma has the potential to transform vaccine delivery pipelines and dramatically improve vaccine access globally which is at the core of our vision”, said Dr Bruce Roser MB BS, PhD, Chairman & Founder of Stablepharma.

“This is a great opportunity for me to work with the team in Madrid and progress with Stablepharma’s novel technology, which will impact people all over the world’, said Lorena, ‘I am delighted to be part of this journey”.

Lorena has contributed to many scientific publications covering such subjects as oncology, tumour infiltration by T cells and mapping the serum proteome of Covid-19 patients.